The validation of analytical methods is a key requirement in the pharmaceutical industry. Learn about the three stages of the FDA guidance.
A significant number of breast cancer patients across the US are using medical cannabis to help cope with symptoms and during treatments.
Based on the 2023 EMA programming document, the forecast for the coming years is a recovery of coordination of inspections and certificate requests.
The therapeutic effect of each preparation is conditioned by its absorption and by the specific metabolites produced within the human body.
AVEVA PI (formerly OSIsoft, recently acquired by AVEVA) is one of the most frequently used platforms for real-time data management.
Technology is revolutionizing women's healthcare in India and making a significant impact on reaching those previously inaccessible.
In the pharmaceutical industry, adoption of CCS and the implementation of QRM are critical for organizations to guarantee product quality and safety.
The EMA has introduced the QRD Template Version 9.0 for product information used by the MAH. The updated template must be adopted by January 2027.
The Israeli Health Ministry announced the eagerly awaited medical cannabis reforms in a statement published on August 7, 2023.
Pharmacists play a crucial role in preparing medical cannabis in accordance with established regulations and guidelines.
